title: Dopamine as a synaptic transmitter and modulator in sympathetic ganglia: a different mode of synaptic action.
abstract: An analysis of the role of adrenergic transmission in mediating the hyperpolarizing, slow inhibitory postsynaptic potential has revealed that dopamine is apparently the specific synaptic transmitter for this response. An additional action of dopamine was discovered, namely the selective facilitation of another synaptic response, the slow excitatory postsynaptic potential. (This potential is a depolarizing response to the muscarinic action of acetylcholine.) This second, modulatory, role of dopamine has characteristics strikingly different from other known modes of synaptic action. After a brief initial action by dopamine, the facilitation of the slow excitatory postsynaptic potential response can persist for hours and is unaffected by a delayed blockade of the postsynaptic receptors for dopamine. This suggests that the modulation consists of a long-lasting metabolic and/or structural change induced in the postsynaptic neuron by dopamine. These conclusions are based on the demonstrated actions of dopamine and other catecholamines, as well as on effects (on dopamine actions and on slow postsynaptic potentials of alpha-adrenergic blockers, of blockade, of dopamine oxidase, of depletion of ganglionic catecholamine by muscarinic excitation, and of a selective re-uptake of dopamine after such depletion.
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001338:Autonomic Fibers, Postganglionic / Q000502:physiology; D001626:Bethanechol Compounds / Q000494:pharmacology; D004156:Catechol Oxidase / Q000037:antagonists & inhibitors; D004298:Dopamine / Q000378:metabolism / Q000502:physiology*; D004357:Drug Synergism; D004594:Electrophysiology / Q000187:drug effects; D004837:Epinephrine / Q000494:pharmacology; D005725:Ganglia, Autonomic / Q000502:physiology*; D066298:In Vitro Techniques; D008688:Methacholine Compounds / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010477:Perfusion; D011817:Rabbits; D013268:Stimulation, Chemical; D013569:Synapses / Q000502:physiology*; D009435:Synaptic Transmission / Q000187:drug effects; D013859:Thiocarbamates / Q000494:pharmacology; D013997:Time Factors
chemical_list: D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D001626:Bethanechol Compounds; D008688:Methacholine Compounds; D013859:Thiocarbamates; D004156:Catechol Oxidase; D000109:Acetylcholine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine